Fundraising Fox

Peca Labs

Pittsburgh, US · Founded 2012 · Delaware corporation

PECA Labs develops cardiovascular implants—including vascular grafts and the MASA Valve, a polymeric bi-leaflet valved conduit for pulmonary valve reconstruction—based on a proprietary tunable polymeric material platform. Its devices target both pediatric and adult patients, with the MASA Valve currently under investigational use in a U.S. clinical trial.

Biotech Healthtech Medical Devices New Materials

Founders & leadership

Peca Labs was founded in 2012 by C. Douglas Bernstein.

CD

C. Douglas BernsteinCEO

DS

David SmithExecutive

Board

SN

Samuel Navarro

Samuel NavarroBoard director

MM

Michael MoriartyBoard director

DJ

Dr. Jeffrey Carpenter

Dr. Jeffrey CarpenterBoard director

JO

Jeff O?DonnellBoard director

JK

Jon KuhnBoard director

DJ

Dr. Joseph BavariaBoard director

BH

Brandon HaynesBoard director

BC

Barbara CarryerBoard director

RK

Rajan KalraBoard director

Reported raises · per SEC filings

Form D private placements

$21.4M disclosed across 9 rounds · 2015–2025

▶$2.7MraisedNov 2025 · 18 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Brandon HaynesDirector
Dr. Joseph BavariaDirector
Barbara CarryerDirector
Jon KuhnDirector
Dr. Jeffrey CarpenterDirector
Michael MoriartyDirector
Samuel NavarroDirector
C. Douglas BernsteinExecutive Officer, Director
Jeff O?DonnellDirector

Offering amount: $5M
Amount sold: $2.7M
First sale: Nov 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$13.9MraisedDec 2024 · 32 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Michael MoriartyDirector
Dr. Jeffrey CarpenterDirector
Samuel NavarroDirector
Jeff O?DonnellDirector
Jon KuhnDirector
C. Douglas BernsteinExecutive Officer, Director
Dr. Joseph BavariaDirector
Brandon HaynesDirector
Barbara CarryerDirector

Offering amount: $16.5M
Amount sold: $13.9M
First sale: Dec 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$618.2KraisedNov 2022 · 6 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Barbara CarryerDirector
Michael MoriartyDirector
David SmithExecutive Officer
James BrowneDirector
Douglas BernsteinExecutive Officer, Director
Jon KuhnDirector

Amount sold: $618.2K
First sale: Nov 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$99.2KraisedJul 2021 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Robert DicksonDirector
Michael MoriartyDirector
Jon KuhnDirector
Babs CarryerDirector
Douglas BernsteinExecutive Officer, Director
David SmithExecutive Officer
James BrowneDirector

Offering amount: $1.8M
Amount sold: $99.2K
First sale: Jun 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$587.5KraisedJun 2020 · 5 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

James BrowneDirector
Robert DicksonDirector
Jon KuhnDirector
Michael MoriartyDirector
David SmithExecutive Officer
Douglas BernsteinExecutive Officer, Director
Babs CarryerDirector

Offering amount: $2.1M
Amount sold: $587.5K
First sale: Jun 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$93.8KraisedFeb 2019 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Robert DicksonDirector
Michael MoriartyDirector
James BrowneDirector
Douglas BernsteinExecutive Officer, Director
David SmithExecutive Officer
Jon KuhnDirector
Babs CarryerDirector

Offering amount: $1.6M
Amount sold: $93.8K
First sale: Jan 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.4MraisedFeb 2018 · 4 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Babs CarryerDirector
David SmithExecutive Officer
James BrowneDirector
Robert DicksonDirector
Michael MoriartyDirector
Douglas BernsteinExecutive Officer, Director

Offering amount: $1.4M
Amount sold: $1.4M
First sale: Jan 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$750KraisedNov 2016 · 5 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

David SmithExecutive Officer
Michael MoriartyDirector
Robert DicksonDirector
Douglas BernsteinExecutive Officer, Director
Babs CarryerDirector
James BrowneDirector

Offering amount: $750K
Amount sold: $750K
First sale: Nov 2016
Incorporated: Corporation, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Edwards Lifesciences3 shared keywordsEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.

Companies competing with Peca Labs for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2019	$998K
National Institutes of Health (NIH)National Institutes of Health	Phase I	2017	$149.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Pittsburgh Pennsylvania based Peca Labs is raising $2,099,998.00 in New Equity Investment. - intelligence360intelligence360.news · Jul 2020

Peca Labs raises venture funding - Smart Business Dealmakerssmartbusinessdealmakers.com · Jun 2020

Frequently asked questions

What does Peca Labs do?: PECA Labs develops cardiovascular implants—including vascular grafts and the MASA Valve, a polymeric bi-leaflet valved conduit for pulmonary valve reconstruction—based on a proprietary tunable polymeric material platform. Its devices target both pediatric and adult patients, with the MASA Valve currently under investigational use in a U.S. clinical trial.
Who founded Peca Labs?: Peca Labs was founded by C. Douglas Bernstein in 2012.
How much funding has Peca Labs raised?: Peca Labs has disclosed $21.4M raised across 9 rounds.
Where is Peca Labs headquartered?: Peca Labs is headquartered in Pittsburgh, US.